India’s long wait for a dengue vaccine may finally be coming to an end. Takeda’s tetravalent dengue vaccine, TAK-003 (called ‘Qdenga’), recently received clearance from the Subject Expert Committee ...

An international team of researchers has demonstrated that the tetravalent dengue vaccine known as Qdenga provided significant protection against the disease under real-world conditions, during the ...

Please provide your email address to receive an email when new articles are posted on . Qdenga offered protection against all four dengue serotypes for 7 years, Takeda said. The vaccine is not ...

With a new manufacturing partnership in India, Takeda has added new firepower to its stated goal of producing 100 million doses of dengue fever vaccine Qdenga annually by the end of the decade. Takeda ...

Mosquito-Borne Diseases: Hopes are rising for a dengue vaccine called Qdenga. According to reports, this vaccine could be launched in India by 2026. Let's explain it. When will the Qdenga vaccine ...

Annapurna Das, General Manager, Takeda Biopharmaceuticals India Pvt Ltd, with 20 years of experience in the pharmaceutical and biotechnology industry across India and Southeast Asia, spoke to ETPharma ...

An international team of researchers has demonstrated that the tetravalent dengue vaccine Qdenga provides significant protection against the disease under real-world conditions, during the large 2024 ...